Ficolin-3-mediated lectin complement pathway activation in patients with subarachnoid hemorrhage

Neurology

Volumn 82, Issue 2, 2014, Pages 126-134

  Zanier, Elisa R ^a   Zangari, Rosalia ^a,b   Munthe Fog, Lea ^c   Hein, Estrid ^c   Zoerle, Tommaso ^a   Conte, Valeria ^b   Orsini, Franca ^a   Tettamanti, Mauro ^a   Stocchetti, Nino ^b   Garred, Peter ^c   De Simoni, Maria Grazia ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; FICOLIN; FICOLIN 1; FICOLIN 3; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG; FCN3 PROTEIN, HUMAN; GLYCOPROTEIN; LECTIN;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPLEMENT LECTIN PATHWAY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; HUMAN TISSUE; MALE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; URINARY TRACT INFECTION; VASOSPASM; YOUNG ADULT; AGED; BLOOD; BRAIN VASOSPASM; COHORT ANALYSIS; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; NEUROSURGERY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; COHORT STUDIES; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84895773012     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000020     Document Type: Article

References (39)

1. Algra AM, Klijn CJ, Helmerhorst FM, Algra A, Rinkel GJ. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology 2012;79:1230-1236.
2. De Rooij NK, Linn FH, Van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007;78:1365-1372.
3. Plesnila N. Pathophysiological role of global cerebral ischemia following subarachnoid hemorrhage: the current experimental evidence. Stroke Res Treat 2013;2013:651958.
4. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2315-2321.
5. Sabri M, Lass E, Macdonald RL. Early brain injury: a common mechanism in subarachnoid hemorrhage and global cerebral ischemia. Stroke Res Treat 2013;2013:394036.
6. Cervera A, Planas AM, Justicia C, et al. Geneticallydefined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One 2010;5:e8433.
7. Orsini F, Villa P, Parrella S, et al. Targeting mannosebinding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation 2012;126:1484-1494.
8. Gesuete R, Storini C, Fantin A, et al. Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol 2009;66: 332-342.
9. Füst G, Munthe-Fog L, Illes Z, et al. Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation 2011;8:185.
10. Osthoff M, Katan M, Fluri F, et al. Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS One 2011;6:e21338.
11. Yongqing T, Drentin N, Duncan RC, Wijeyewickrema LC, Pike RN. Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions? Biochim Biophys Acta 2012;1824:253-262.
12. Schwaeble W, Dahl MR, Thiel S, Stover C, Jensenius JC. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes. Immunobiology 2002;205:455-466.
13. Skjoedt MO, Palarasah Y, Munthe-Fog L, et al. MBLassociated serine protease-3 circulates in high serum concentrations predominantly in complex with ficolin-3 and regulates ficolin-3 mediated complement activation. Immunobiology 2010;215:921-931.
14. Hummelshoj T, Fog LM, Madsen HO, Sim RB, Garred P. Comparative study of the human ficolins reveals unique features of ficolin-3 (Hakata antigen). Mol Immunol 2008;45:1623-1632.
15. Csuka D, Munthe-Fog L, Skjoedt MO, et al. A novel assay to quantitate MASP-2/ficolin-3 complexes in serum. J Immunol Methods 2013;387:237-244.
16. Zanier ER, Brandi G, Peri G, et al. Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. Intensive Care Med 2011;37:302-309.
17. Zanier ER, Zoerle T, Fiorini M, et al. Heart-fatty acidbinding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. Br J Anaesth 2013;111:424-432.
18. Diringer MN, Bleck TP, Claude Hemphill J III, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011;15:211-240.
19. Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988;51:1457.
20. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9.
21. Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B. Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma 1998;15:587-597.
22. Dhar R, Scalfani MT, Blackburn S, Zazulia AR, Videen T, Diringer M. Relationship between angiographic vasospasm and regional hypoperfusion in aneurysmal subarachnoid hemorrhage. Stroke 2012;43:1788-1794.
23. Garred P, Honoré C, Ma YJ, Munthe-Fog L, Hummelshøj T. MBL2, FCN1, FCN2 and FCN3: the genes behind the initiation of the lectin pathway of complement. Mol Immunol 2009;46:2737-2744.
24. Munthe-Fog L, Hummelshøj T, Hansen BE, et al. The impact of FCN2 polymorphisms and haplotypes on the ficolin-2 serum levels. Scand J Immunol 2007;65:383-392.
25. Munthe-Fog L, Hummelshøj T, Ma YJ, et al. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 2008;45:2660-2666.
26. Munthe-Fog L, Hummelshoj T, Honoré C, et al. Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation. Genes Immun 2012;13:515-522.
27. Skjoedt MO, Roversi P, Hummelshøj T, et al. Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolinassociated protein-1 (MAP-1). J Biol Chem 2012;287: 32913-32921.
28. Hein E, Honoré C, Skjoedt MO, Munthe-Fog L, Hummelshøj T, Garred P. Functional analysis of ficolin-3 mediated complement activation. PLoS One 2010;5:e15443.
29. Sallenbach S, Thiel S, Aebi C, et al. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 2011;22:424-430.
30. Mack WJ, Ducruet AF, Hickman ZL, et al. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 2007;61:255-260.
31. Naredi S, Lambert G, Friberg P, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med 2006;32: 1955-1961.
32. Széplaki G, Szegedi R, Hirschberg K, et al. Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes. Atherosclerosis 2009;204: 315-320.
33. Osthoff M, Rovó A, Stern M, et al. Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation. Haematologica 2010;95:1389-1396.
34. Jensen ML, Honoré C, Hummelshøj T, Hansen BE, Madsen HO, Garred P. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 2007;44:856-865.
35. Wang CC, Yim KW, Poon TC, et al. Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin Chem 2007;53:42-52.
36. Prohászka Z, Munthe-Fog L, Ueland T, et al. Association of ficolin-3 with severity and outcome of chronic heart failure. PLoS One 2013;8:e60976.
37. Eisen DP, Dean MM, Boermeester MA, et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008;47: 510-516.
38. Jeon YT, Lee JH, Lee H, et al. The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2012;24:317-324.
39. Kasius KM, Frijns CJ, Algra A, Rinkel GJ. Association of platelet and leukocyte counts with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2010;29:576-583.